Exact Sciences
EXAS
#1157
Rank
A$29.02 B
Marketcap
A$152.07
Share price
0.00%
Change (1 day)
86.96%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -A$0.29 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$3.24 Billion. , an increase over its 2024 earnings that were of -A$1.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.27 Billion-82.05%
2024 -A$1.48 Billion435.05%
2023 -A$0.28 Billion-69.18%
2022 -A$0.9 Billion-25.77%
2021 -A$1.21 Billion1.68%
2020 -A$1.19 Billion271.17%
2019 -A$0.32 Billion58.99%
2018 -A$0.21 Billion20.89%
2017 -A$0.17 Billion-30.95%
2016 -A$0.25 Billion5.09%
2015 -A$0.23 Billion57.24%
2014 -A$0.15 Billion116.53%
2013 -A$67.11 Million
2011 -A$41.78 Million143.73%
2010 -A$17.15 Million27.85%
2009 -A$13.41 Million0.27%
2008 -A$13.38 Million-20.95%
2007 -A$16.92 Million-13.53%
2006 -A$19.57 Million-10.07%
2005 -A$21.76 Million-21.81%
2004 -A$27.83 Million-33.44%
2003 -A$41.81 Million-6.51%
2002 -A$44.71 Million17.95%
2001 -A$37.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$11.10 B-4,302.85%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$89.77 M-133.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$95.49 M-136.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.61 Billion 129.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$50.69 Million-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA